Comparison of carotid intima-media thickness between hemodialysis and peritoneal dialysis patients

Nur Samsu1, Mala Hayati2, Eden Suryoiman Winoto3

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Jawa Timur, Indonesia. nur_samsu.fk@ub.ac.id.

Insights

Peritoneal dialysis (PD) patients exhibit lower carotid intima-media thickness (cIMT) than hemodialysis (HD) patients, indicating reduced cardiovascular risk. Klotho may play a role in this protective effect by stabilizing atherosclerotic plaques.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Patients with chronic kidney disease (CKD) face elevated cardiovascular disease (CVD) risks.
  • Carotid intima-media thickness (cIMT) is a key indicator of CVD risk.
  • Klotho is linked to improved atherosclerotic plaque stability in CKD patients.

Purpose of the Study:

  • To examine the relationship between dialysis modality and cIMT in dialysis patients.
  • To compare cIMT levels between hemodialysis (HD) and peritoneal dialysis (PD) patients.
  • To explore the role of FGF-23 and Klotho in dialysis-related atherosclerosis.

Main Methods:

  • A cross-sectional study involving 83 dialysis patients (40 HD, 43 PD).
  • Data collection included patient history, carotid artery ultrasonography for cIMT, and laboratory tests.
  • cIMT was measured across six carotid artery segments.

Main Results:

  • PD patients demonstrated significantly lower cIMT compared to HD patients (P = 0.005).
  • Younger age was independently associated with lower cIMT in PD patients (P = 0.003).
  • PD patients had a lower FGF23/Klotho ratio than HD patients (P = 0.039).
  • In PD patients, calcium, phosphorus, and CaxP product correlated positively with FGF-23, but this correlation weakened with the FGF-23/Klotho ratio.

Conclusions:

  • Peritoneal dialysis is associated with lower cIMT than hemodialysis.
  • Younger age is a significant factor in reduced cIMT.
  • Klotho appears to mitigate the positive correlation between CaxP product and FGF-23/Klotho ratio, potentially contributing to lower cIMT in PD patients.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...